Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Mucosal signatures of pathogenic T cells in HLA-B*27+ anterior uveitis and axial spondyloarthritis
Michael A. Paley, … , K. Christopher Garcia, Wayne M. Yokoyama
Michael A. Paley, … , K. Christopher Garcia, Wayne M. Yokoyama
Published July 18, 2024
Citation Information: JCI Insight. 2024;9(16):e174776. https://doi.org/10.1172/jci.insight.174776.
View: Text | PDF
Research Article

Mucosal signatures of pathogenic T cells in HLA-B*27+ anterior uveitis and axial spondyloarthritis

  • Text
  • PDF
Abstract

HLA-B*27 was one of the first HLA alleles associated with an autoimmune disease, i.e., axial spondyloarthritis (axSpA) and acute anterior uveitis (B27AAU), which cause joint and eye inflammation, respectively. Gastrointestinal inflammation has been suggested as a trigger of axSpA. We recently identified a bacterial peptide (YeiH) that can be presented by HLA-B*27 to expanded public T cell receptors in the joint in axSpA and the eye in B27AAU. While YeiH is present in enteric microbiota and pathogens, additional evidence that pathogenic T cells in HLA-B*27–associated autoimmunity may have had a prior antigenic encounter within the gastrointestinal tract remains lacking. Here, we analyzed ocular, synovial, and blood T cells in B27AAU and axSpA, showing that YeiH-specific CD8+ T cells express a mucosal gene set and surface proteins consistent with intestinal differentiation, including CD161, integrin α4β7, and CCR6. In addition, we found an expansion of YeiH-specific CD8+ T cells in axSpA and B27AAU blood compared with that from individuals acting as healthy controls, whereas influenza-specific CD8+ T cells were equivalent across groups. Finally, we demonstrated the dispensability of TRBV9 for antigen recognition. Collectively, our data suggest that, in HLA-B27–associated autoimmunity, early antigen exposure and differentiation of pathogenic CD8+ T cells may occur in enteric organs.

Authors

Michael A. Paley, Xinbo Yang, Lynn M. Hassman, Frank Penkava, Lee I. Garner, Grace L. Paley, Nicole Linskey, Ryan Agnew, Paulo Henrique Arantes de Faria, Annie Feng, Sophia Y. Li, Davide Simone, Elisha D.O. Roberson, Philip A. Ruzycki, Ekaterina Esaulova, Jennifer Laurent, Lacey Feigl-Lenzen, Luke E. Springer, Chang Liu, Geraldine M. Gillespie, Paul Bowness, K. Christopher Garcia, Wayne M. Yokoyama

×

Figure 5

Peptide expansion and tetramer sorting identifies alternative TCR motifs for recognition of YeiH.232-240.

Options: View larger image (or click on image) Download as PowerPoint
Peptide expansion and tetramer sorting identifies alternative TCR motifs...
(A) Cartoon of in vitro expansion of CD8+ T cells specific for NP.383-391 or YeiH.232-240. PBMCs are pulsed with NP.383-391 or YeiH.232-240 to generate “stimulators,” which are then combined with autologous “responder” PBMCs and cultured for 7–10 days to allow for expansion of NP.383-391 or YeiH.232-240–specific CD8+ T cells. (B) Representative flow cytometry of PBMCs from an individual acting as a healthy control (left) or participant with B27AAU and/or axSpA (right) after 8 days of culture with NP.383-391–pulsed (top) or YeiH.232-240–pulsed (bottom) autologous PBMCs. Plots show antigen-specific expansion of tetramer+ CD8+ T cells. Plots are representative of 4 separate experiments. (C) Side view of detailed peptide engagement through superimposed 026.1/135.1 TCR CDR1α and CDR3β. The TCRα chain is colored deep salmon red, the TCRβ chain is colored bright orange, the peptide is colored magenta, and the HLA-B*27:05 is colored green. (D) Side view of interactions between 026.1/135.1 TCR CDR2α and HLA-B*27:05. The TCRα chain is colored deep salmon red, and the HLA-B*27:05 is colored green.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts